Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rhoptry neck protein 2 (RON2) is a transmembrane protein component of the moving junction complex that mediates parasite invasion in apicomplexan parasites, including the malaria parasite *Plasmodium*. RON2 functions as a receptor for the parasite surface protein AMA1 (Apical Membrane Antigen 1), and this interaction is essential for forming the tight junction structure that enables parasites to invade host cells, whether merozoites invading red blood cells or sporozoites invading salivary gland and hepatocyte cells. The RON2-AMA1 interaction is highly conserved across *Plasmodium* species, making it an attractive drug target. Blocking this interaction with antibodies, peptides, or small molecule inhibitors effectively prevents parasite invasion. The crystal structures of RON2-AMA1 complexes have been solved, revealing the molecular basis for binding specificity and enabling structure-based drug design approaches for antimalarial therapeutics.
Blocking the AMA1-RON2 interaction prevents the formation of the moving junction complex, thereby inhibiting parasite invasion
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rhoptry neck protein 2 (RON2).